Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small cell lung cancer
Pharma
Jazz to withdraw Zepzelca in second-line small cell lung cancer
The decision comes after the confirmatory phase 3 Lagoon trial of Zepzelca recently failed on its primary endpoint of overall survival.
Angus Liu
Aug 4, 2026 9:18am
Zepzelca saga takes another turn with ph. 3 lung cancer flop
Jun 12, 2026 10:48am
Jazz, Roche's small cell lung cancer combo snags FDA approval
Oct 3, 2025 10:00am
BeOne bags $885M in Royalty deal on Amgen's Imdelltra
Aug 25, 2025 10:34am
ASCO: Amgen's Imdelltra prolongs life in small cell lung cancer
Jun 2, 2025 8:00am
ASCO: Roche, Jazz lung cancer win leaves room for improvement
May 22, 2025 5:00pm
